NCT Number: NCT02637102
The UK CAVIAR Study
CAVIAR is a multicentre prospective observational study. Centres for cardiac and vascular surgery assess and manage patients in different ways before surgery. Some centres have introduced the use of intravenous iron therapy for patients with anaemia in the preoperative setting. Consequently regional variation exists in the assessment and management of patients before cardiac and vascular surgery. We aim to observe and measure these differing pathways and observe if there is variation in iron deficiency and anaemia and the impact of these variables on patient cardiorespiratory function as well as post-operative outcomes.
[Sub-Study] For patients who are receiving intravenous iron therapy as part of their routine clinical care, we wish to observe this effect in more detail. We will assess the impact of the treatment on well-being, blood count and fitness. Information will be collected through Quality of Life questionnaires, total haemoglobin mass test (via blood collection) and fitness testing.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Male and female adults aged 18 years or older
- Screening [Hb] < 120 g/L (for females) or < 130g/L (for males)
- Undergoing elective cardiac OR vascular surgery:
- Coronary artery bypass (CABG), or valvular surgery, or combined CABG and valve surgery.
- Repair or replacement of thoracic or abdominal aorta (open or endovascular).
- Able to provide informed consent
- (if applicable) Able to perform CPET or 6MWT if consented to take part in the sub study
Exclusion criteria
- Pregnancy or lactation
- Adults with known underlying history of learning disabilities, or adults who do not have mental capacity to consent for themselves
- Prisoners
- Renal dialysis (current or planned within the next 12 months)
Treatment and study plan
Primary outcomes
-
Change in Haemoglobin
Time frame: From baseline to before surgery (within 10-42 days)
Secondary outcomes
-
Changes in biomarkers of iron deficiency (e.g. hepcidin, ferritin, TfSats)
Time frame: From baseline to after IV iron (within 4-6 weeks before surgery)
-
Haemoglobin
Time frame: Before surgery (within 10-42 days) to post surgery (within 3 weeks)
-
Unit of blood transfused
Time frame: Hospital stay (within 7 days)
-
ICU and hospital length of stay
Time frame: Within 30 days
-
Renal function (change in creatinine)
Time frame: From baseline to before surgery (within 10-42 days)
-
Renal function (change in creatinine)
Time frame: From baseline to post surgery (within 3 weeks)
-
Complications
Time frame: Within 30 days post surgery
-
Feasibility - number of successful patient recruitment and consent
Time frame: Within a year
-
Total haemoglobin mass test (Sub-study ONLY)
Time frame: From baseline to after IV iron (within 4-6 weeks before surgery)
-
Functional exercise testing (CPET or 6MWT) (Sub-study ONLY)
Time frame: From baseline to after IV iron (within 4-6 weeks before surgery)
-
Quality of Life (Sub-Study ONLY)
Time frame: From baseline to i) after IV iron (within 4-6 weeks before surgery), ii) post surgery (within 3 weeks)
Sponsors and collaborators
Lead sponsor
University College, London
Other
Registry information
Official study title
The UK CArdiac and Vascular Surgery Interventional Anaemia Response Study: An Observational Cohort Study to Determine the Impact and Effect of Anaemia in Patients Awaiting Vascular and Cardiac Surgery
Important dates
- Study start
- 2015
- Primary completion
- 2018
- Study completion
- 2019
- First posted
- Dec 22, 2015
- Registry last updated
- May 16, 2023
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Effect of an Oral Nutritional Supplement on the Nutritional and Health Outcomes of the Elderly
NCT06773975
Anaemia, Anemia
Accra, Greater Accra Region, Ghana
View Trial DetailsBioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia
NCT06080555
Anaemia, Anemia
Beijing, Beijing Municipality, China
View Trial DetailsFerinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)
NCT00520780
Anaemia, Anemia
Buenos Aires, Argentina
View Trial DetailsSwitch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)
NCT02232906
Anaemia, Anemia
Buenos Aires, Argentina
View Trial Details